EZR and osteosarcoma: Ezrin, a member of the ERM (ezrin-radixin-moesin) family of cytoskeleton adaptor proteins, is frequently overexpressed in invasive cancers and is associated with disease progression and poor overall survival in multiple malignancies, including breast, pancreatic, ovarian, colorectal, and osteosarcoma (6).